4//SEC Filing
QUINLAN KEVIN W 4
Accession 0001140361-10-002976
CIK 0000898437other
Filed
Jan 27, 7:00 PM ET
Accepted
Jan 28, 4:10 PM ET
Size
5.7 KB
Accession
0001140361-10-002976
Insider Transaction Report
Form 4
QUINLAN KEVIN W
Chief Financial Officer
Transactions
- Award
Stock Appreciation Rights
2010-01-26+25,000→ 25,000 totalExercise: $6.36Exp: 2020-01-26→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]The stock appreciation rights vest in four equal installments annually beginning January 26, 2011.
Documents
Issuer
ANIKA THERAPEUTICS INC
CIK 0000898437
Entity typeother
Related Parties
1- filerCIK 0001209114
Filing Metadata
- Form type
- 4
- Filed
- Jan 27, 7:00 PM ET
- Accepted
- Jan 28, 4:10 PM ET
- Size
- 5.7 KB